Cormedix's market cap is currently ―. The company's EPS TTM is $-0.917; its P/E ratio is -5.90; Cormedix is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	$ 29.70K	$ 6.82K
Gross Profit	-	-	-	$ 29.30K	$ 5.35K
EBIT	$ -9.73M	$ -11.27M	$ -10.56M	$ -8.38M	$ -6.84M
EBITDA	$ -9.68M	$ -11.22M	$ -10.51M	$ -8.33M	$ -6.82M
Net Income Common Stockholders	$ -9.74M	$ -11.27M	$ -10.57M	$ -8.21M	$ -6.85M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 86.59M	$ 52.49M	$ 55.73M	$ 58.92M	$ 59.00M
Total Assets	$ 91.43M	$ 57.03M	$ 59.23M	$ 62.04M	$ 62.08M
Total Debt	$ 702.95K	$ 736.86K	$ 770.01K	$ 802.43K	$ 834.01K
Net Debt	$ -85.88M	$ -51.75M	$ -54.96M	$ -58.11M	$ -58.17M
Total Liabilities	$ 8.23M	$ 7.98M	$ 5.31M	$ 6.98M	$ 5.76M
Stockholders Equity	$ 83.20M	$ 49.05M	$ 53.93M	$ 55.06M	$ 56.31M
Cash Flow	-
Free Cash Flow	$ -8.71M	$ -8.58M	$ -10.41M	$ -6.28M	$ -6.07M
Operating Cash Flow	$ -8.70M	$ -8.57M	$ -10.39M	$ -6.15M	$ -6.00M
Investing Cash Flow	$ -586.87K	$ -2.39M	$ -14.69M	$ -1.86K	$ -114.28K
Financing Cash Flow	$ 42.90M	$ 5.35M	$ 7.20M	$ 6.05M	$ 437.29K

Currency in USD

Cormedix Earnings and Revenue History

Income Statement >

Cormedix Debt to Assets

Balance Sheet >

Cormedix Cash Flow

Cash Flow >

Cormedix Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing